From October 1, 2023 to December 31, 2023, the company has repurchased 1,349,500 shares, representing 2.95% for ¥4,246.78 million. With this, the company has completed the repurchase of 1,664,100 shares, representing 3.63% for ¥5,196.6 million under the buyback announced on May 8, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3,130 JPY | -1.73% | -14.25% | +1.29% |
05-08 | Japanese Shares Swing to Red Amid Profit-Taking, US Rate Cut Uncertainty | MT |
05-08 | Kissei Pharmaceutical's Attributable Profit Jumps 6% in Fiscal 2023; Shares Tumble 11% | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.29% | 903M | |
+7.39% | 72.81B | |
+12.72% | 9.13B | |
-10.56% | 5.13B | |
+58.79% | 4.99B | |
+4.07% | 3.9B | |
-16.90% | 2.48B | |
+20.21% | 2.42B | |
-27.82% | 2.32B | |
+25.13% | 2.17B |
- Stock Market
- Equities
- 4547 Stock
- News Kissei Pharmaceutical Co., Ltd.
- Tranche Update on Kissei Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 8, 2023.